Exhibit 10.5
THERAVANCE,
INC.
AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE PLAN
AND SUMMARY PLAN DESCRIPTION
(As amended July 27, 2007)
The Theravance, Inc. Amended and Restated Change in Control Severance Plan (the Plan) is primarily designed to provide separation pay and other benefits to Theravance, Inc. (the Corporation) executives who meet the eligibility requirements as set forth below (an Eligible Executive) and whose employment is involuntarily terminated in connection with a change in control occurring after an initial public offering (IPO).
This Plan is designed to be an employee welfare benefit plan, as defined in Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (ERISA). This Plan is governed by ERISA and, to the extent applicable, the laws of the State of California. This document constitutes both the official plan document and the required summary plan description under ERISA.
You will be an Eligible Executive for severance benefits under the Plan if:
· you are an officer of the Corporation;
· your active employment is Involuntarily Terminated other than for Misconduct within the designated period following a Change in Control;
· you execute a waiver and general release of all claims in a form provided by and acceptable to the Corporation as provided for in the section entitled Release and Waiver of Claims, within the prescribed number of days following your date of termination, as set forth in such release; and
· you are not in one of the excluded categories listed below.
You will not be an Eligible Executive for severance benefits under this Plan if:
· you are an independent contractor, a temporary employee, part-time employee working fewer than 32 hours per week, probationary employee or student employee;
· you are employed with a successor employer following a Change in Control. However, you would be eligible for severance benefits pursuant to the terms of the Plan upon a subsequent Involuntary Termination other than for Misconduct within the designated period following a Change in Control; or
· you are dismissed for Misconduct.
If you are an Eligible Executive and your employment is Involuntarily Terminated within three (3) months before or twenty-four (24) months after a Change in Control, you will be paid a Severance Payment calculated as follows:
If you were an officer of the Corporation immediately before the Change in Control:
· 100% of your combined Annual Base Pay and Target Bonus, plus
· A pro-rata portion of your current target bonus based on the number of full months of employment completed in the applicable period on the date of termination in such year of termination.
If you were senior vice president of the Corporation immediately before the Change in Control:
· 150% of your combined Annual Base Pay and Target Bonus, plus
· A pro-rata portion of your current target bonus based on the number of full months of employment completed in the applicable period on the date of termination in such year of termination.
If you were the chief executive officer or an executive vice president of the Corporation immediately before the Change in Control:
· 200% of your combined Annual Base Pay and Target Bonus, plus
· A pro-rata portion of your current target bonus based on the number of full months of employment completed in the applicable period on the date of termination in such year of termination.
Payments made under this Plan shall not be treated as compensation for purposes of the Theravance, Inc. 401(k) Profit Sharing Plan. An Eligible Executive will also receive his unpaid salary through his termination date and a lump sum payment for all accrued and unused vacation (through the termination date) in a final paycheck provided on his last day of work.
The full amount of any balance and accrued interest remaining on any outstanding loans owed by the Eligible Executive to the Corporation as of the date of termination shall be forgiven in full immediately upon the Eligible Executives Involuntary Termination.
The Severance Payment under this subsection 1 shall be paid in one lump sum from the general assets of the Corporation on the first scheduled payroll date of the Corporation following the latest of the following dates: the Eligible Executives last day of employment, the date the Corporation receives the Eligible Executives signed release, or the date the revocation period (if any) specified in the release expires. If the release has not been signed by the Eligible Executive and become effective by the date that is two and one-half months after the end of the year in
2
which employment ceases, then the Eligible Executive will cease to be eligible for benefits under this Plan.
If an Eligible Executive becomes entitled to a Severance Payment under this Plan, then the Corporation shall continue to provide all welfare benefits provided on the date of termination to the Eligible Executive and, if applicable, to the Eligible Executives dependents for the following periods:
· 12 months if you were an officer of the Corporation immediately before the Change in Control
· 18 months if you were a senior vice president of the Corporation immediately before the Change in Control
· 24 months if you were the chief executive officer or an executive vice president of the Corporation immediately before the Change in Control
The Corporations obligation to pay premiums or make contributions shall cease when the Eligible Executive obtains new employment offering comparable welfare benefits. All welfare benefits, other than pursuant to COBRA, shall cease on the last day of the second calendar year following the year in which the separation from service occurs. The Corporation will pay the monthly premium under COBRA for the Eligible Executive and, if applicable, his or her dependents until the earliest of (a) the end of the period of 12, 18 or 24 months (as applicable based on the formula set forth above) following the month in which the Eligible Executives employment terminates or (b) the expiration of the Eligible Executives continuation coverage under COBRA.
Annual Base Pay shall mean the Eligible Executives base salary at the highest rate in effect at any regularly scheduled payroll period preceding the occurrence of the Change in Control and does not include, for example, bonuses, overtime compensation, incentive pay, sales commissions or expense allowances.
3
Target Bonus shall mean the normal bonus amount that would be paid for achieving 100% of goals or MBOs as used in the applicable annual bonus plan.
Involuntary Termination shall mean the termination of the service of the Eligible Executive which occurs by reason of:
Misconduct shall mean the commission of any material act of fraud, embezzlement or dishonesty by an individual, any material unauthorized use or disclosure by such person of confidential information or trade secrets of the Corporation (or any Parent or Subsidiary), or any other intentional material misconduct by such person adversely affecting the business or affairs of the Corporation (or any Parent or Subsidiary).
Change in Control shall mean:
4
(i) |
|
had been directors of the Corporation on the date 24 months prior to the date of such change in the composition of the Board (the Original Directors) or |
|
|
|
|
(ii) |
|
were appointed to the Board, or nominated for election to the Board, with the affirmative votes of at least a majority of the aggregate of (A) the Original Directors who were in office at the time of their appointment or nomination and (B) the directors whose appointment or nomination was previously approved in a manner consistent with this clause (ii); or |
Except with respect to a GSK Change In Control (defined below), (i) any stock purchase by SmithKline Beecham Corporation, a Pennsylvania corporation (GSK), pursuant to the Class A Common Stock Purchase Agreement dated as of March 30, 2004 or (ii) the exercise by GSK of any of its rights under the Amended and Restated Governance Agreement dated as of June 4, 2004 among the Corporation, GSK, GlaxoSmithKline plc and Glaxo Group Limited (the Governance Agreement) to representation on the Board (and its committees) or (iii) any acquisition by GSK of securities of the Company (whether by merger, tender offer, private or market purchases or otherwise) not prohibited by the Governance Agreement shall not constitute a Change in Control. A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Corporations incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Corporations securities immediately before such transaction. A GSK Change In Control shall mean the acquisition by GSK of the Companys Voting Stock (as defined in the Governance Agreement) that would bring GSKs Percentage Interest (as defined in the Governance Agreement) to 100% in compliance with the provisions of the Governance Agreement.
The Internal Revenue Code imposes a 20% excise tax on certain payments and other benefits received by certain officers and shareholders in connection with a change of control involving the Corporation. Such payments can include severance pay, loan forgiveness and acceleration of option vesting.
Gross-Up Payment.
In the event that it is determined that any payment or distribution of any type to or for the benefit of the Eligible Executive made by the Corporation, by any of its affiliates, by any person who acquires ownership or effective control of the Corporation or ownership of a substantial portion
5
of the Corporations assets (within the meaning of section 280G of the Code and the regulations thereunder) or by any affiliate of such person, whether paid or payable or distributed or distributable pursuant to the terms of this Plan or under any other agreement including an Eligible Executives stock option agreement and including loan forgiveness (the Total Payments), would be subject to the excise tax imposed by section 4999 of the Code or any interest or penalties with respect to such excise tax (such excise tax, together with any such interest or penalties, are collectively referred to as the Excise Tax), then the Corporation shall pay Eligible Executive an additional amount (a Gross-Up Payment) equal to the amount that shall fund the payment by the Eligible Executive of any Excise Tax on the Total Payments as well as all income taxes imposed on the Gross-Up Payment, any Excise Tax imposed on the Gross-Up Payment and any interest or penalties imposed with respect to taxes on the Gross-Up Payment or any Excise Tax.
Determination by Accountant.
All mathematical determinations and all determinations of whether any of the Total Payments are parachute payments (within the meaning of section 280G of the Code) that are required to be made under this Section 5, including all determinations of whether a Gross-Up Payment is required, of the amount of such Gross-Up Payment and of amounts relevant to the last sentence of this section, shall be made by an independent accounting firm selected by the Corporation (the Accounting Firm), which shall provide its determination (the Determination), together with detailed supporting calculations regarding the amount of any Gross-Up Payment and any other relevant matters, both to the Corporation and to the Eligible Executive within seven business days of the Eligible Executives termination date, if applicable, or such earlier time as is requested by the Corporation or by the Eligible Executive (if the Eligible Executive reasonably believes that any of the Total Payments may be subject to the Excise Tax). If the Accounting Firm determines that no Excise Tax is payable by the Eligible Executive, it shall furnish the Eligible Executive with a written statement that such Accounting Firm has concluded that no Excise Tax is payable (including the reasons therefor) and that the Eligible Executive has substantial authority not to report any Excise Tax on the Eligible Executives federal income tax return. If a Gross-Up Payment is determined to be payable, it shall be paid to the Eligible Executive within five business days after the Determination is delivered to the Corporation or the Eligible Executive and in no event later than the close of the calendar year following the calendar year in which the Eligible Executive pays the Excise Tax. Any determination by the Accounting Firm shall be binding upon the Corporation and the Eligible Executive, absent manifest error.
Underpayments and Overpayments.
As a result of uncertainty in the application of section 4999 of the Code at the time of the initial Determination by the Accounting Firm hereunder, it is possible that Gross-Up Payments not made by the Corporation should have been made (Underpayments) or that Gross-Up Payments will have been made by the Corporation which should not have been made (Overpayments). In either event, the Accounting Firm shall determine the amount of the Underpayment or Overpayment that has occurred. In the case of an Underpayment, the amount of such Underpayment shall promptly be paid by the Corporation to or for the benefit of the Eligible Executive. In the case of an Overpayment, the Eligible Executive shall, at the direction and expense of the Corporation, take such steps as are reasonably necessary (including the filing of returns and claims for refund), follow reasonable instructions from, and procedures established
6
by, the Corporation and otherwise reasonably cooperate with the Corporation to correct such Overpayment; provided, however, that (i) the Eligible Executive shall in no event be obligated to return to the Corporation an amount greater than the net after-tax portion of the Overpayment that the Eligible Executive has retained or has recovered as a refund from the applicable taxing authorities and (ii) this provision shall be interpreted in a manner consistent with the intent of this section, which is to make the Eligible Executive whole, on an after-tax basis, for the application of the Excise Tax, it being understood that the correction of an Overpayment may result in the Eligible Executives repaying to the Corporation an amount which is less than the Overpayment.
This Section 6 shall only apply if the Corporation determines that the Eligible Executive is a specified employee under Section 409A(a)(2)(B)(i) of the Code and the regulations thereunder when his or her employment terminates. If this Section 6 applies, it shall supersede any contrary provision of this Agreement. To the extent that no exemption from Section 409A of the Code is available for the benefits under Section 1, 2 or 5, such payments shall commence on the earliest practicable date that occurs more than six months after the Eligible Executives employment terminates. The severance payments or benefits that otherwise would have been made during the first six months following the termination date shall be paid in a lump sum on the first day of the seventh month after the termination date.
7
8
As a participant in the Plan, you are entitled to certain rights and protections under ERISA. ERISA provides that all Plan participants shall be entitled to:
1. Examine, without charge, at the Plan Administrators office, all Plan documents, including all documents filed by the Plan with the U.S. Department of Labor.
2. Obtain copies of all Plan documents and other Plan information upon written request to the Plan Administrator. The Plan Administrator may make a reasonable charge for the copies.
3. File suit in a federal court, if you, as a participant, request materials and do not receive them within thirty (30) days of your request. In such a case, the court may require the Plan Administrator to provide the materials and to pay you a fine of up to $100 for each days delay until the materials are received, unless the materials were not sent because of reasons beyond the control of the Plan Administrator.
In addition to creating rights for certain employees of the Corporation under the Plan, ERISA imposes obligations upon the people who are responsible for the operation of the Plan. The people who operate the Plan (called fiduciaries) have a duty to do so prudently and in the interest of the Corporations employees who are covered by the Plan.
No one, including your employer or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a benefit to which you are entitled under the Plan or from exercising your rights under ERISA.
If your claim for a severance benefit is denied or ignored, in whole or in part, you have a right to file suit in a federal or a state court. If Plan fiduciaries are misusing the Plans assets (if any) or if you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor or file suit in a federal court. The court will decide who will pay court costs and legal fees. If you are successful in your lawsuit, the court may, if it so decides, order the party you have sued to pay your legal costs, including attorney fees. However, if you lose, the court may order you to pay these costs and fees, for example, if it finds that your claim or suit is frivolous.
If you have any questions about the Plan, this statement or your rights under ERISA, you should contact the Plan Administrator or the nearest Area Office of the U.S. Labor-Management Services Administration, Department of Labor.
9
ADDITIONAL PLAN INFORMATION
|
Name of Plan: |
Theravance, Inc. Amended and Restated Change in Control Severance Plan |
|
|
|
|
Corporation Sponsoring Plan: |
Theravance, Inc. 901 Gateway
Boulevard |
|
|
|
|
Employer Identification Number: |
94-3265960 |
|
|
|
|
Plan Number: |
506 |
|
|
|
|
Plan Year: |
The calendar year; the first plan year shall end December 31, 2004 |
|
|
|
|
Plan Administrator: |
Theravance, Inc. 901 Gateway
Boulevard |
|
|
|
|
Agent for Service of Legal Process: |
Plan Administrator |
|
|
|
|
Type of Plan: |
Severance Plan/Employee Welfare Benefit Plan |
|
|
|
|
Plan Costs: |
The cost of the Plan is paid by Theravance, Inc. |
10